|
Volumn 8, Issue 6 SUPPL., 2001, Pages 16-21
|
Fever and neutropenia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
AMPHOTERICIN B LIPID COMPLEX;
ANTIFUNGAL AGENT;
CASPOFUNGIN;
DALFOPRISTIN PLUS QUINUPRISTIN;
LINEZOLID;
ACETAMIDE DERIVATIVE;
ANTI INFECTIVE AGENTS;
ANTIINFECTIVE AGENT;
ANTINEOPLASTIC AGENT;
OXAZOLIDINONE DERIVATIVE;
POLYPEPTIDE ANTIBIOTIC AGENT;
QUINUPRISTIN-DALFOPRISTIN;
VIRGINIAMYCIN;
ANTIBIOTIC RESISTANCE;
ANTIFUNGAL ACTIVITY;
BLOOD CULTURE;
BONE MARROW TOXICITY;
CONFERENCE PAPER;
FEVER;
GRAM POSITIVE BACTERIUM;
HUMAN;
INFECTION RISK;
MYCOSIS;
NEPHROTOXICITY;
NEUTROPENIA;
PRACTICE GUIDELINE;
RISK ASSESSMENT;
BACTERIAL INFECTION;
CATHETERIZATION;
MICROBIOLOGY;
NEOPLASM;
RISK FACTOR;
TREATMENT OUTCOME;
ACETAMIDES;
ANTI-INFECTIVE AGENTS;
ANTIBIOTICS, ANTIFUNGAL;
ANTIBIOTICS, PEPTIDE;
ANTINEOPLASTIC AGENTS;
CATHETERIZATION, PERIPHERAL;
FEVER;
GRAM-POSITIVE BACTERIAL INFECTIONS;
HUMAN;
NEOPLASMS;
NEUTROPENIA;
OXAZOLIDINONES;
RISK ASSESSMENT;
RISK FACTORS;
TREATMENT OUTCOME;
VIRGINIAMYCIN;
|
EID: 0035192125
PISSN: 10732748
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (6)
|
References (14)
|